Overview

Effects of Huperzine A on Presbycusis(Δ,kHz, dB,MMSE, AD)

Status:
Enrolling by invitation
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
To investigate the effects of huperzine A on tinnitus suppression, hearing and cognitive function protection in patients with presbycusis-related subjective tinnitus and cognitive impairment.
Phase:
N/A
Details
Lead Sponsor:
Zhijun Bao
Treatments:
Cholinesterase Inhibitors
Huperzine A